September 27, 2020


Will Global Artificial Organs bag a good market?

According to TechSci Research, Artificial Organs will gain a major confidence in the market by 2025. Chronic diseases are increasing exponentially.As a result single or multiple organ failure and lack of healthy organ donors contribute to the growth of this market. Studies state that the Global Artificial Organ Market can be categorized based on by the type of Organ ,by the type of technology,by the type of fixation,by the type of material,by Region Forecast by 2025. This market will gain a huge popularity because the artificial organs have the ability to restore the normal functioning of the human organs.As stated the chronic diseases are increasing exponentially therefore the number of organ transplants have increased as a result the demand for the artificial organs are increasing. There is a surge in the number of accidents and several major injuries which also is a big factor in increasing the demand. Due to this new concept of artificial organ transplant the mortality rate will be reduced shortly and these days people are very conscious of a better and healthy living. Thus, the acceptance rate of artificial organ transplant has also increased specially among the aged people having chronic diseases owing to the age. The increasing use and demand of bio-artificial materials contribute greatly towards this market. People are getting more familiar with this new concept.

However,there are multiple reasons hindering the growth and development of this sector. Product failure  and the overall expenditure of the artificial organs is a common problem.

Major companies in the field of global artificial organs market include Cochlear Ltd., B. Braun Melsungen AG, Abiomed Inc., Biomet Inc., Baxter International Inc., Edward Lifesciences Corporation, Syncardia, Boston Scientific Corporation, Asahi Kasei Medical Co. Ltd, Heartware International, Inc, Dexcom, Inc., Ekso Bionics, OTTO Bock Healthcare GmbH, Jarvik Heart, Inc., Advanced Bionics AG and affiliates, Fresenius Medical Care AG & Co. KGaA, Med-El Electromedizinische Gerate GmbH, Medtronic, Plc, Retina Implant AG and Nipro Corporation.  New product are being launched continuously,research & development activities  are going on a continuous basis to enhance their product portfolio. Major business,growth and marketing strategies are being used to increase their market share. 

According to Mr. Karan Chechi, Research Director with TechSci Research, North America is leading the market of global artificial organs because Trump’s administration has high budgets and expenditures fixed for the health-care sector. Also the region has a growing population of aged people having chronic diseases owing to their age. Above all, the population out there can easily afford this modern medical concept based on technology which overall boosts the market for the Global Artificial Organs.

“Global Artificial Organs Market By Organ Type (Artificial Heart (Prosthetic Heart Valves, Ventricular Assist Devices, Cardiac Pacemakers), Artificial Kidney, Artificial Pancreas, Artificial Lungs, Cochlear Implants, Others), By Technology (Electronic Bionics, Mechanical), By Type of Fixation (Wearable, Implantable), By Material Type (Silicon, Plastic, Steel), By Region, Forecast & Opportunities, 2025” helps researchers and analysts to analyze the market trends closely and understand the emerging trends,the probable challenges it poses and the overall profit. Therefore, such intelligence information helps decision makers to make a sound and wise decision for better future prospects.